China Cracks Down On Counterfeit Drugs Under Shanying II Initiative
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China is attempting to crack down on intellectual property rights violations through a two-pronged approach focusing on enforcement actions and preventive measures